GHDX - Genomic Health, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.72B
Enterprise Value 32.58B
Trailing P/E 56.53
Forward P/E 143.87
PEG Ratio (5 yr expected) 12.19
Price/Sales (ttm)6.34
Price/Book (mrq)8.61
Enterprise Value/Revenue 36.02
Enterprise Value/EBITDA 645.39

Trading Information

Stock Price History

Beta (3Y Monthly) 1.36
52-Week Change 327.46%
S&P500 52-Week Change 31.68%
52 Week High 392.18
52 Week Low 350.77
50-Day Moving Average 366.70
200-Day Moving Average 365.89

Share Statistics

Avg Vol (3 month) 3715.54k
Avg Vol (10 day) 3391.36k
Shares Outstanding 537.07M
Float 24.62M
% Held by Insiders 12.77%
% Held by Institutions 186.93%
Shares Short (Jul 31, 2019) 42.72M
Short Ratio (Jul 31, 2019) 42.79
Short % of Float (Jul 31, 2019) 410.19%
Short % of Shares Outstanding (Jul 31, 2019) 47.30%
Shares Short (prior month Jun 28, 2019) 41.61M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 11.69%
Operating Margin (ttm)11.13%

Management Effectiveness

Return on Assets (ttm)8.58%
Return on Equity (ttm)18.48%

Income Statement

Revenue (ttm)428.78M
Revenue Per Share (ttm)11.75
Quarterly Revenue Growth (yoy)19.40%
Gross Profit (ttm)269.19M
EBITDA 56.87M
Net Income Avi to Common (ttm)50.12M
Diluted EPS (ttm)1.30
Quarterly Earnings Growth (yoy)92.20%

Balance Sheet

Total Cash (mrq)243.55M
Total Cash Per Share (mrq)6.53
Total Debt (mrq)57.22M
Total Debt/Equity (mrq)18.04
Current Ratio (mrq)5.74
Book Value Per Share (mrq)8.51

Cash Flow Statement

Operating Cash Flow (ttm)89.03M
Levered Free Cash Flow (ttm)53.89M